Literature DB >> 8702636

Retinoid X receptor alters the determination of DNA binding specificity by the P-box amino acids of the thyroid hormone receptor.

C C Nelson1, S C Hendy, J S Faris, P J Romaniuk.   

Abstract

Nuclear hormone receptors bind to hormone response elements in DNA consisting of two half-sites of 6 base pairs. The P-box amino acids of each receptor determine the identities of the central nucleotides of the half-site. 57 P-box variants of the human thyroid hormone receptor (hT3Rbeta) were used to demonstrate the relationship between P-box sequence and DNA binding specificity by homodimers and heterodimers formed with the retinoid X receptor (RXR). In general, the formation of heterodimers relieved many of the constraints on the compatibility of hT3Rbeta P-box sequences with DNA binding. Effects were most dramatic for heterodimers bound to a direct repeat spaced by four base pairs. RXR also overrides the P-box-derived DNA binding specificity of hT3Rbeta when heterodimers are bound to inverted or everted repeat elements. These effects of RXR are most pronounced on AGGTCA half-sites but are squelched when the RXR partner of the heterodimer is bound to an AGGACA half-site. The influence of RXR on hT3Rbeta DNA binding specificity varies with the orientation of half-sites in the element, the identity of the fourth base pair of the half-site, and the spacing between the half-sites of direct repeats. These differences suggest that the DNA binding domains of RXR-hT3Rbeta heterodimers are not positioned equivalently on the various elements, affecting the manner in which the P-box amino acids of hT3Rbeta interact with base pairs within the half-site.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702636     DOI: 10.1074/jbc.271.32.19464

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  DNA recognition by thyroid hormone and retinoic acid receptors: 3,4,5 rule modified.

Authors:  Theresa Q Phan; Margaret M Jow; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2009-11-27       Impact factor: 4.102

2.  Pushing the limits of what is achievable in protein-DNA docking: benchmarking HADDOCK's performance.

Authors:  Marc van Dijk; Alexandre M J J Bonvin
Journal:  Nucleic Acids Res       Date:  2010-05-13       Impact factor: 16.971

3.  Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis.

Authors:  Meghan D Rosen; Martin L Privalsky
Journal:  J Thyroid Res       Date:  2011-06-08

4.  Overexpressing modified human TRβ1 suppresses the proliferation of breast cancer MDA-MB-468 cells.

Authors:  Xiaoxiang Peng; Yangyang Zhang; Yanli Sun; Lujuan Wang; Wei Song; Qian Li; Ronglan Zhao
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.